Clinical utility of atypical glandular cells (AGC) classification: Cytohistologic comparison and relationship to HPV results

Gynecologic Oncology

Volumn 104, Issue 2, 2007, Pages 366-371

  Diaz Montes, Teresa P ^a   Farinola, Maryam Armin ^b   Zahurak, Marianna L ^c   Bristow, Robert E ^a   Rosenthal, Dorothy L ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adenocarcinoma in situ; AGC; Endocervical adenocarcinoma; HPV

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ATYPICAL GLANDULAR CELL; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CELL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; BIOPSY; DNA, VIRAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33846343659     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.09.001     Document Type: Article

References (32)

1. Oliveira E.R.Z.M., Derchain S.F.M., Rabelo-Santos S.H., Westin M.C.A., Zeferino L.C., Campos E.A., et al. Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening. Diagn. Cytopathol. 31 1 (2004) 19-22
2. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
3. Kurman R.J., and Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy (1994), Springer-Verlag, New York
4. Bose S., Kannan V., and Kline T.S. Abnormal endocervical cells: really abnormal? Really endocervical?. Am. J. Clin. Pathol. 101 6 (1994) 708-713
5. DiTomasso J.P., Ramzy I., and Mody D.R. Glandular lesions of the cervix. Validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma. Acta Cytol. 40 6 (1996) 1127-1135
6. Duska L.R., Flynn C.F., Chen A., Whall-Strojwas D., and Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet. Gynecol. 91 2 (1998) 278-282
7. Eddy G.L., Ural S.H., Strumpf K.B., Wojtowycz M.A., Piraino P.S., and Mazur M.T. Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda System. Gynecol. Oncol. 67 1 (1997) 51-55
8. Goff B.A., Atanasoff P., Brown E., Muntz H.G., Bell D.A., and Rice L.W. Endocervical glandular atypia in Papanicolaou smears. Obstet. Gynecol. 79 1 (1992) 101-104
9. Kennedy A.W., Salmieri S.S., Wirth S.L., Biscotti C.V., Tuason L.J., and Travarca M.J. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol. Oncol. 63 1 (1996) 14-18
10. Nasu I., Meurer W., and Fu Y.S. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int. J. Gynecol. Pathol. 12 3 (1993) 208-218
11. Raab S.S., Bishop N.S., and Zaleski M.S. Effect of cervical disease history on outcomes of women who have a Pap diagnosis of atypical glandular cells of undetermined significance. Gynecol. Oncol. 74 3 (1999) 460-464
12. Veljovich D.S., Stoler M.H., Andersen W.A., Covell J.L., and Rice L.W. Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study. Am. J. Obstet. Gynecol. 179 2 (1998) 382-390
13. Zweizig S., Noller K., Reale F., Collis S., and Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol. Oncol. 65 2 (1997) 314-318
14. Jones B.A., and Novis D.A. Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22439 correlations in 348 laboratories. Arch. Pathol. Lab. Med. 120 6 (1996) 523-531
15. Burja I.T., Thompson S.K., Sawyer Jr. W.L., and Shurbaji M.S. Atypical glandular cells of undetermined significance on cervical smears: a study with cytohistologic correlation. Acta Cytol. 43 3 (1999) 351-356
16. Mody D.R. Agonizing over AGUS. Cancer Cytopathol. 87 5 (1999) 243-244
17. Raab S.S., Isacson C., Layfield L.J., Lenel J.C., Slagel D.D., and Thomas P.A. Atypical glandular cells of undetermined significance. Cytologic criteria to separate clinically significant from benign lesions. Am. J. Clin. Pathol. 104 5 (1995) 574-582
18. Schindler S., Pooley Jr. R.J., DeFrias D.V., Yu G.H., and Bedrossian C.W. Follow-up of atypical glandular cells in cervical-endocervical smears. Ann. Diagn. Pathol. 2 5 (1998) 312-317
19. Soofer S.B., and Sidawy M.K. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer Cytopathol. 90 4 (2000) 207-214
20. Cangiarella J.F., and Chhieng D.C. Atypical glandular cells-an update. Diagn. Cytopathol. 29 5 (2003) 271-279
21. Ronnett B.M., Manos M.M., Ransley J.E., Fetterman B.J., Kinney W.K., Hurley L.B., et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum. Pathol. 30 7 (1999) 816-825
22. Taylor R.R., Guerrieri J.P., Nash J.D., Henry M.R., and O'Connor D.M. Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J. Reprod. Med. 38 6 (1993) 443-447
23. Wilbur D.C. Endocervical glandular atypia: a "new" problem for the cytologist. Diagn. Cytopathol. 13 5 (1995) 463-469
24. Cullimore J.E., Luesley D.M., Rollason T.P., Byrne P., Buckley C.H., Anderson M., et al. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN)-a preliminary report. Br. J. Obstet. Gynaecol. 99 4 (1992) 314-318
25. Andersen E.S., and Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol. Oncol. 35 1 (1989) 1-7
26. Levine L., Lucci III J.A., and Dinh TV. Atypical glandular cells: new Bethesda terminology and management guidelines. Obstet. Gynecol. Surv. 58 6 (2003) 399-406
27. Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G., et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am. J. Pathol. 157 4 (2000) 1055-1062
28. Irvin W., Evans S.R., Andersen W., Jazaeri A., Taylor P., Stoler M., et al. The utility of HPV DNA triage in the management of cytological AGC. Am. J. Obstet. Gynecol. 193 2 (2005) 559-565
29. Baker J.J. Conventional and liquid-based cervicovaginal cytology: a comparison study with clinical and histologic follow-up. Diagn. Cytopathol. 27 3 (2002) 185-188
30. Roberts J.M., Thurloe J.K., Bowditch R.C., Humcevic J., and Laverty CR. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ. Acta Cytol. 43 1 (1999) 74-80
31. Ashfaq R., Gibbons D., Vela C., Saboorian M.H., and Iliya F. ThinPrep Pap test. Accuracy for glandular disease. Acta Cytol. 43 1 (1999) 81-85
32. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., and Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 16 (2002) 2120-2129